CROnos Names Scientific Affairs VP

Dr. Pamela Keenan has been appointed vice president of Scientific Affairs at CROnos Clinical Consulting. Dr. Keenan will serve as the primary liaison to biopharma customers, vendors and investigative sites for the company’s Alzheimer’s disease practice area.
 
Dr. Keenan joins the company from Johnson & Johnson, where she most recently served in Global Medical Affairs for Janssen Alzheimer Immunotherapy. Dr. Keenan has more than 20 years of experience in Alzheimer’s disease as a clinician and researcher in the pharma industry. Dr. Keenan also served as director of the Adult Neuropsychology Program at Wayne State University School of Medicine, where she was responsible for clinical training and research programs.
 
“Pamela is an accomplished leader with global experience across all phases of Alzheimer’s Disease clinical trials,” said Guillermo Di Clemente, president and founder, CROnos. “Having worked in large pharma for many years, she brings strong customer insight which allows her to anticipate our customers’ needs. This insight, along with her scientific background, will be instrumental in strengthening our customer relationships and the delivery of our innovative quality assurance solutions.”